Brief: CMS Sets Rate Of $897 For Immunovia's Immray Pancan-D Test
30/11/2022 08:54
Nov 30 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* CENTERS FOR MEDICARE & MEDICAID SERVICES FINALIZES ITS
PAYMENT
DETERMINATION AND SETS A RATE OF $897 FOR IMMUNOVIA'S IMMRAY
PANCAN-D TEST
Source text for Eikon: ID:nWkr5QgSmw
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study